About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Platelet PAR-1 Activation in Health and Diabetes

NCT04280549·1 site·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

Vanderbilt University Medical Center

Age

60–any

Sex

ALL

Healthy volunteers

Accepted

You may be eligible if

Healthy men and women ≥60 years of age OR
Type 2 diabetic men and women ≥60 years of age

You may not be if

Active cancer
Prior myocardial infarction, prior stroke, diagnosed peripheral artery disease
Severe liver (cirrhosis, cancer, or end-stage liver disease), kidney disease (eGFR \<30 cc/min).
Pregnancy or lactation
Active vasculitis
Anticipated lifespan \< 2 years
Current use of a DOAC

The record

StatusCompleted

PhaseNo phase

Taking part100

StartedJun 2018

UpdatedMar 19, 2025

Conditions

Type 2 Diabetes Healthy

Where1

Vanderbilt University Medical Center
Nashville, Tennessee, United States

Clareo Health | Platelet PAR-1 Activation in Health and Diabetes